Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP991832.RAUhArAKz3ni2OF0wwkY4_LrfuYgY_LRanF6XaMFssj0A130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP991832.RAUhArAKz3ni2OF0wwkY4_LrfuYgY_LRanF6XaMFssj0A130_assertion type Assertion NP991832.RAUhArAKz3ni2OF0wwkY4_LrfuYgY_LRanF6XaMFssj0A130_head.
- NP991832.RAUhArAKz3ni2OF0wwkY4_LrfuYgY_LRanF6XaMFssj0A130_assertion description "[The strategy was successfully used to establish LCLs expressing Wilms' tumor gene 1 (WT1) tumor antigen (WT1-LCLs), which is an attractive target for cancer immunotherapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP991832.RAUhArAKz3ni2OF0wwkY4_LrfuYgY_LRanF6XaMFssj0A130_provenance.
- NP991832.RAUhArAKz3ni2OF0wwkY4_LrfuYgY_LRanF6XaMFssj0A130_assertion evidence source_evidence_literature NP991832.RAUhArAKz3ni2OF0wwkY4_LrfuYgY_LRanF6XaMFssj0A130_provenance.
- NP991832.RAUhArAKz3ni2OF0wwkY4_LrfuYgY_LRanF6XaMFssj0A130_assertion SIO_000772 22722376 NP991832.RAUhArAKz3ni2OF0wwkY4_LrfuYgY_LRanF6XaMFssj0A130_provenance.
- NP991832.RAUhArAKz3ni2OF0wwkY4_LrfuYgY_LRanF6XaMFssj0A130_assertion wasDerivedFrom befree-20150227 NP991832.RAUhArAKz3ni2OF0wwkY4_LrfuYgY_LRanF6XaMFssj0A130_provenance.
- NP991832.RAUhArAKz3ni2OF0wwkY4_LrfuYgY_LRanF6XaMFssj0A130_assertion wasGeneratedBy ECO_0000203 NP991832.RAUhArAKz3ni2OF0wwkY4_LrfuYgY_LRanF6XaMFssj0A130_provenance.